ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102817; 2) Community: the network communities that were significantly associated with the response to NSC 102817; 3) Molecule: the relationships between components within communities and NSC 102817; 4) MDR: the compounds that were significantly associated with the NSC 102817.

NSC Compound Enrichment Correlation
NSC 621486 2-Propen-1-one, 1-(1,4-dioxo-2,6,7-trimethylquinoxalin- 3-yl)-3-(2-nitrophenyl)- 0.000395532514722381 -0.2785244
NSC 637578 N-[3-(2-Pyridyl)isoquinolin-1-yl]-2-pyridinecarboxamidine 0.000395532514722381 0.56978178
NSC 666038 Piperidinone, 1-methyl-3,5-bis[(2-nitrophenyl) methylene]-, hydrochloride 0.000395532514722381 0.77941604
NSC 670687 Null 0.000395532514722381 0.72603334
NSC 8120 Claviform 0.000395532514722381 0.77873181
NSC 529108 4-Fluoro-D,L-tryptophan 0.000483960412931737 0.17300552
NSC 657348 Null 0.000483960412931737 0.19034373
NSC 681114 Null 0.000483960412931737 0.13897603
NSC 732122 2-[3-(Benzothiazol-2-ylsulfanyl)-3-(4-methoxy-phenyl)-allyli dene]-malononitrile 0.000483960412931737 0.3169455
NSC 335766 Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- 0.000574000735425498 0.44553862
Total:136  Current:6    [First] [Prev] [Next] [Last]